Impact Analysis of Covid-19
The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Chronic sinusitis affects more than 31 million people in the United States. It is more prevalent than heart disease and asthma and has a greater impact on patients' quality of life than chronic back pain or congestive heart failure. The majority of patients with chronic sinusitis are treated with oral antibiotics and/or nasal steroids, which can increase the risk of antibiotic resistance and cause unwanted side effects such as epistaxis (nose bleeds), nasal ulcers, and nasal and oral infections. The most effective treatments are Functional Endoscopic Sinus Surgery (FESS) and balloon dilation at high pressures, which are known to cause significant patient discomfort and are conducted in a surgical suite under general anesthesia or IV sedation.
Scope of the Report:
The classification of Sinus Dilation Devices includes Balloon Sinus Dilation and No-Balloon Sinus Dilation. The proportion of Balloon Sinus Dilation in 2016 is about 97%, and the proportion is in decreasing trend from 2012 to 2016.
Sinus Dilation Devices is widely used in Physician's Office and Operating Room. The most proportion of Sinus Dilation Devices is Operating Room, and the proportion in 2016 is 51%. The trend of Operating Room is in decrease trend.
North America is the largest supplier of Sinus Dilation Devices, with a production market share nearly 96% in 2016.
North America is the largest consumption place, with a consumption market share nearly 85% in 2016.
Market competition is not intense. Acclarent, Entellus Medical, Medtronic, Smith & Nephew are the leaders of the industry.
The worldwide market for Sinus Dilation Devices is expected to grow at a CAGR of roughly 14.7% over the next five years, will reach 760 million US$ in 2024, from 340 million US$ in 2019, according to a new WMR study.
This report focuses on the Sinus Dilation Devices in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Smith & Nephew,
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Balloon Sinus Dilation
No-Balloon Sinus Dilation
Market Segment by Applications, can be divided into
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Sinus Dilation Devices product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Sinus Dilation Devices, with price, sales, revenue and global market share of Sinus Dilation Devices in 2017 and 2018.
Chapter 3, the Sinus Dilation Devices competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Sinus Dilation Devices breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Sinus Dilation Devices market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Sinus Dilation Devices sales channel, distributors, customers, research findings and conclusion, appendix and data source.